Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently.

Radioligand therapy (RLT) has helped change what’s possible in prostate cancer treatment, but Novartis continues to work on the next wave of innovations to bring new options to patients.

Novartis researchers are using data to accelerate drug development.

Novartis researchers use automation to rapidly identify starting points for new drugs.

Experts call for significant changes to facilitate the discovery of new treatments.